Chao Fu

Title: Chao Fu: Innovator in Quinoline Derivatives

Introduction

Chao Fu is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of quinoline derivatives. His work focuses on compounds that have potential therapeutic applications in immunomodulation and cancer treatment.

Latest Patents

Chao Fu holds 1 patent for a quinoline derivative that exhibits indoleamine-2,3-dioxygenase inhibitory activity. This patent describes a compound of general Formula (I) or its pharmaceutically acceptable salts. The invention includes its pharmaceutical composition, preparation method, and its use in manufacturing a medicament aimed at immunomodulating and preventing or treating diseases associated with IDO expression abnormalities and tryptophan metabolism disorders. Additionally, the patent discusses the use of a combination medication of the quinoline derivative and HDAC inhibitors in the development of anti-tumor drugs.

Career Highlights

Chao Fu is affiliated with Shenzhen Chipscreen Biosciences, Ltd., where he continues to advance his research in medicinal chemistry. His innovative work has the potential to impact the treatment of various diseases, particularly those related to immune system regulation and cancer.

Collaborations

Chao Fu collaborates with Lijun Xin, contributing to the advancement of their shared research goals. Their partnership enhances the development of new therapeutic strategies in the field of biomedicine.

Conclusion

Chao Fu's contributions to the field of medicinal chemistry, particularly through his patent on quinoline derivatives, highlight his role as an innovator in developing new therapeutic options. His work continues to pave the way for advancements in treating diseases associated with immune system abnormalities and cancer.